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In the Netherlands, screening for tick-borne pathogens
is performed using real time PCR on DNA extracted
from ticks, followed by sequencing of positive samples,
thereby disallowing identification in case of double-
infections. Until recently, testing was performed with
several reverse line blots (RLBs), each containing ~10
different probes. Advantages of RLBs are the capabilities
to differentiate between bacterial species and to detect
double infections, disadvantages are that RLBs are fasti-
dious, elaborate, and time-consuming.
The aim of this work was to ‘test drive’ bead-based sus-
pension arrays for the rapid detection and identification
of tick-borne Borrelia species. The platform used is the
flow cytometry-based xMAP technology of Luminex, in
which fluorescent nanoparticles (beads) are used to build
multiplex assays simply by mixing different bead sets that
are covered with specific probes. Each bead set contains
a different ratio of red and infrared fluorophores, which
enables identification of beads that pick up a third fluoro-
phore by hybridization to a labelled target molecule.
Using standard chemistry, aminated oligonucleotides
were covalently linked to carboxylated Luminex beads,
resulting in bead sets with general and specific probes for
the 23S-5S intergenic spacer (IGS) of Borrelia species.
Presence of probes on the beads was verified by hybridi-
zation of complementary biotinylated oligonucleotides in
presence of a mixture of 1000 beads per bead set, using a
30 minute incubation at 37°C in a NaCl/Tris buffer,
followed by labelling with streptavidin-phycoerythrin. Of
each mixture, a minumum of 100 beads per bead set
were investigated by flow cytometry on a dedicated
Luminex instrument.
To evaluate the suspension array, DNA of nearly 1000
ticks was isolated and used to generate amplicons with a
universal PCR targeting the 23S-5S IGS of Borrelia spp.
All PCR reactions were then used in a direct hybridiza-
tion assay in presence of a mixture of probe-containing
beads. Out of 981 ticks, ~20% were found to carry one or
more Borrelia species (resp. 15 and 5%). The most preva-
lent species was B. afzelii, followed by B. burgdorferi
sensu stricto, B. garinii, B. sensu lato (unidentified) and
B. valaisiana. These results show the viability of bead-
based suspension arrays for (relatively) rapid detection
and identification of multiple species, but at this
stage need verification by a ‘gold standard’. Currently,
confirmation of these results is being performed by next
generation sequencing.
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